Synthesis of L-[5-11C]Leucine and L-α-[5-11C]Methylleucine via Pd0-mediated 11C-Methylation and Microfluidic Hydrogenation: Potentiality of Leucine PET Probes for Tumor Imaging

The efficient synthesis of L-[5-C-11]leucine and L-alpha-[5-C-11]methylleucine has been investigated using a continuous two-step sequence of rapid reactions consisting of Pd-0-mediated C-11-methylation and microfluidic hydrogenation. The synthesis of L-[5-C-11]leucine and L-alpha-[5-C-11]methylleucine was accomplished within 40 min with a decay-corrected radiochemical yield of 15-38 % based on [C-11]CH3I, radiochemical purity of 95-99 %, and chemical purity of 95-99 %. The Pd impurities in the injectable solution measured using inductively coupled plasma mass spectrometry met the international criteria for human use. Positron emission tomography scanning after an intravenous injection of L-[5-C-11]leucine or L-alpha-[5-C-11]methyl leucine in A431 tumor-bearing mice was performed. As a result, L-alpha-[5-C-11]methylleucine was found to be a potentially useful probe for visualizing the tumor. Tissue distribution analysis showed that the accumulation value of L-alpha-[5-C-11]methylleucine in tumor tissue was high [12 +/- 3% injected dose/g tissue (%ID/g)].

Automated summary

Efficient synthesis of L-[5-C-11]leucine and L-alpha-[5-C-11]methylleucine was achieved using a two-step sequence, with promising potential of L-alpha-[5-C-11]methylleucine as a probe for visualizing tumors confirmed through tissue distribution analysis.